IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia.
Explore this paper's citation graph
Summary
Evidence of a link-involving IL-17-between psoriasis and hyperglycemia in humans and mice is provided by Ikumi et al.
- Type
- article
- Published
- 2019-06-01
- Cited by
- 12
- References
- 16
- Access
- Open access
- OpenAlex
- https://openalex.org/W31126427
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:164218561
Keywords
Computer science
References
- Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study
- Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1
- TGF-βi Promotes Islet β-Cell Function and Regeneration
- Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom
- Metabolic syndrome: definitions and controversies
- Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus.
- Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink.
- The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia
- Elevated Levels of T-helper 17-associated Cytokines in Diabetes Type I Patients: Indicators for Following the Course of Disease
- Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents
- Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis
- Psoriasis and Comorbid Diseases Part I. Epidemiology
- Psoriasis Pathogenesis and the Development of Novel, Targeted Immune Therapies
- Hyperglycemia Is Associated with Psoriatic Inflammation in Both Humans and Mice.
Cited by
- The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): Protocol for a Two-Arm Pilot Randomized Controlled Open Cross-over Study
- Therapeutic wavelengths of ultraviolet B radiation activate apoptotic, circadian rhythm, redox signalling and key canonical pathways in psoriatic epidermis
- Prevalence of psoriasis in a cohort of children and adolescents with type 1 diabetes
- Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions
- Metabolic Disorders and Psoriasis: Exploring the Role of Nutritional Interventions
- Effects of biological agents on glycogen metabolism in psoriasis patients: A systematic review and meta‐analysis
- Oral administration of punicalagin attenuates imiquimod‐induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF‐κB signaling pathways
- Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota
- Residual metabolic burden in young psoriasis patients successfully treated with biologics
- Cardiometabolic Risk in Psoriatic Arthritis: A Hidden Burden of Inflammation and Metabolic Dysregulation
- Adapting Glucagon-Like Peptide-1 Receptor Agonists for Innovative Psoriasis Therapy.
- The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): a two-arm pilot randomized controlled open cross-over study
Related papers
No related papers recorded.